MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1
Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regu...
Saved in:
Published in | Irish journal of medical science Vol. 193; no. 2; pp. 909 - 916 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.
Aims
This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).
Methods
GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (
n
= 35), simple steatosis (
n
= 35), and NASH (
n
= 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR‐582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.
Results
miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients’ plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers’ expression but induced cell apoptosis, via TMBIM1.
Conclusions
This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1. |
---|---|
AbstractList | The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.
This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).
GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.
miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.
This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1. Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs). Methods GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis ( n = 35), simple steatosis ( n = 35), and NASH ( n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR‐582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro. Results miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients’ plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers’ expression but induced cell apoptosis, via TMBIM1. Conclusions This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1. The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.BACKGROUNDThe gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).AIMSThis study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.METHODSGSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.RESULTSmiR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.CONCLUSIONSThis present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1. |
Author | Huang, Shuo Wu, Hongman Zhou, Feng Xiao, Xia Fu, Chenchao |
Author_xml | – sequence: 1 givenname: Shuo surname: Huang fullname: Huang, Shuo organization: Department of Internal Medicine, Hunan Maternal and Child Health Hospital – sequence: 2 givenname: Xia surname: Xiao fullname: Xiao, Xia organization: Department of Internal Medicine, Hunan Maternal and Child Health Hospital – sequence: 3 givenname: Hongman surname: Wu fullname: Wu, Hongman organization: Department of Infection Control Center, Xiangya Hospital of Central South University – sequence: 4 givenname: Feng surname: Zhou fullname: Zhou, Feng organization: Department of Infection Control Center, Xiangya Hospital of Central South University – sequence: 5 givenname: Chenchao surname: Fu fullname: Fu, Chenchao email: Fuchenchao6112@163.com organization: Department of Infection Control Center, Xiangya Hospital of Central South University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37823951$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb1OHDEYRa0IFBbIC6SIXKYx8b89JUFJQGKDhLa3PB4Pa5gZT2xPVtR58Xiz0KSgcnPOtb57T8HRFCcPwEeCLwjG6ksmRHOBMGUIM0EbtHsHVkRLhjiT9AisMKYEESrFCTjN-RFj1jDJ34MTpjRljSAr8GcdXIr3Py-R0BSxGT5N0T11cTdBOwz-d7DFZ1g_RnZwcRuH4GAu3pa49bMtoYQM2-fKFp_C9ADL1sOHpcBxH9uGWCx0cZxjrmSsmVMHx9j5VNVKb9Zfb9bkHBz3dsj-w8t7Bjbfv22urtHt3Y-bq8tb5BhXBWnFqabK2h43jVLatRJz2lnFGypEy3rmrHaN7ySXXS8s4ayXnuPeeSYsZWfg8yF2TvHX4nMxY8jOD4OdfFyyoVpJybgWrKKfXtClHX1n5hRGm57Na28V0AegXplz8r1xodj9iSXZMBiCzX4ic5jI1InMv4nMrqr0P_U1_U2JHaQ872v2yTzGJU21rbesv-3tpV4 |
CitedBy_id | crossref_primary_10_3390_onco5010009 crossref_primary_10_3390_ijms25158042 crossref_primary_10_1136_gutjnl_2024_332398 |
Cites_doi | 10.3350/cmh.2022.0237 10.1016/j.tim.2018.10.011 10.1016/j.jnutbio.2017.02.003 10.1007/s11684-018-0645-9 10.1002/hep4.1479 10.1038/nm.4334 10.1111/imm.12390 10.1136/gutjnl-2018-316723 10.1002/hep.26494 10.1056/NEJMoa2029349 10.1016/j.drudis.2022.05.003 10.1097/tp.0000000000002484 10.1111/tra.12488 10.1016/j.addr.2017.05.007 10.1007/s11845-022-02988-x 10.1016/s0140-6736(20)32511-3 10.2147/ceg.S262879 10.1016/j.jhep.2013.12.019 10.1111/febs.12806 10.1007/s11154-019-09512-0 10.1016/j.trsl.2019.07.007 10.1038/s41366-021-00985-1 10.3390/jcm5030038 10.3389/fendo.2020.597648 10.3390/ijms20020395 10.3390/cells9061534 10.1093/advances/nmy078 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1007/s11845-023-03529-w |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1863-4362 |
EndPage | 916 |
ExternalDocumentID | 37823951 10_1007_s11845_023_03529_w |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6NX 78A 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMOR ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACUDM ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADQRH ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEGXH AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFEXP AFFNX AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AHYZX AIAGR AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG5 HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV KPH LLZTM M4Y MA- MK0 N2Q NDZJH NF0 NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PT4 PT5 QOK QOR R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XAX YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ACSTC ADHKG AFDZB AFOHR AGQPQ AHPBZ ATHPR AYFIA CITATION ABRTQ NPM 7X8 |
ID | FETCH-LOGICAL-c347t-8742827aaf099778cb6042da749255b3f3ca8c9ed646df5a143f6e40fce35a23 |
IEDL.DBID | U2A |
ISSN | 0021-1265 1863-4362 |
IngestDate | Fri Jul 11 07:03:30 EDT 2025 Mon Jul 21 05:45:27 EDT 2025 Tue Jul 01 02:09:42 EDT 2025 Thu Apr 24 23:12:05 EDT 2025 Fri Feb 21 02:44:48 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Gut microbiota Hepatic stellate cell Non-alcoholic steatohepatitis MicroRNA-582-3p |
Language | English |
License | 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c347t-8742827aaf099778cb6042da749255b3f3ca8c9ed646df5a143f6e40fce35a23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 37823951 |
PQID | 2876634853 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2876634853 pubmed_primary_37823951 crossref_citationtrail_10_1007_s11845_023_03529_w crossref_primary_10_1007_s11845_023_03529_w springer_journals_10_1007_s11845_023_03529_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20240400 2024-04-00 2024-Apr 20240401 |
PublicationDateYYYYMMDD | 2024-04-01 |
PublicationDate_xml | – month: 4 year: 2024 text: 20240400 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Ireland |
PublicationTitle | Irish journal of medical science |
PublicationTitleAbbrev | Ir J Med Sci |
PublicationTitleAlternate | Ir J Med Sci |
PublicationYear | 2024 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Younossi, Marchesini, Pinto-Cortez, Petta (CR1) 2019; 103 Longo, Tonin Ferrari, Rampelotto (CR14) 2020; 13 CR19 Mennitti, Carpenter, Loche (CR25) 2005; 46 CR13 Ferreira, Simão, Rodrigues, Castro (CR12) 2014; 281 Lee, Wu, Lin (CR7) 2023; 29 Cani (CR20) 2018; 67 Zhao, Zhang, Gong (CR16) 2017; 23 Sud, Zhang, Pan (CR24) 2017; 43 Khan, Gupta, Mahapatra (CR18) 2022; 27 Han, Ma, Li (CR11) 2018; 12 Zhao, Lin, Cheng (CR15) 2019; 214 Yu, Wang, Lai (CR2) 2023; 192 Schoeler, Caesar (CR17) 2019; 20 Guerrero-Mandujano, Hernández-Cortez, Ibarra, Castro-Escarpulli (CR21) 2017; 18 Bajaj, Heuman, Hylemon (CR10) 2014; 60 CR4 Chassaing, Etienne-Mesmin, Gewirtz (CR9) 2014; 59 Higashi, Friedman, Hoshida (CR26) 2017; 121 Parthasarathy, Revelo, Malhi (CR6) 2020; 4 CR8 Sanyal, Van Natta, Clark (CR5) 2021; 385 CR27 Smyth, Boardman, Tung (CR23) 2015; 144 Aguilar, Mano, Eulalio (CR22) 2019; 27 Powell, Wong, Rinella (CR3) 2021; 397 JS Bajaj (3529_CR10) 2014; 60 N Sud (3529_CR24) 2017; 43 C Aguilar (3529_CR22) 2019; 27 EE Powell (3529_CR3) 2021; 397 ZM Younossi (3529_CR1) 2019; 103 M Schoeler (3529_CR17) 2019; 20 LA Smyth (3529_CR23) 2015; 144 T Higashi (3529_CR26) 2017; 121 B Chassaing (3529_CR9) 2014; 59 3529_CR27 AJ Sanyal (3529_CR5) 2021; 385 L Longo (3529_CR14) 2020; 13 PD Cani (3529_CR20) 2018; 67 X Yu (3529_CR2) 2023; 192 3529_CR4 DM Ferreira (3529_CR12) 2014; 281 R Han (3529_CR11) 2018; 12 3529_CR13 LV Mennitti (3529_CR25) 2005; 46 3529_CR8 AA Khan (3529_CR18) 2022; 27 KC Lee (3529_CR7) 2023; 29 Z Zhao (3529_CR15) 2019; 214 G Parthasarathy (3529_CR6) 2020; 4 GN Zhao (3529_CR16) 2017; 23 3529_CR19 A Guerrero-Mandujano (3529_CR21) 2017; 18 |
References_xml | – volume: 29 start-page: 77 year: 2023 end-page: 98 ident: CR7 article-title: Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis publication-title: Clin Mol Hepatol doi: 10.3350/cmh.2022.0237 – volume: 27 start-page: 206 year: 2019 end-page: 218 ident: CR22 article-title: MicroRNAs at the host-bacteria interface: host defense or bacterial offense publication-title: Trends Microbiol doi: 10.1016/j.tim.2018.10.011 – volume: 43 start-page: 125 year: 2017 end-page: 131 ident: CR24 article-title: Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2017.02.003 – ident: CR4 – volume: 12 start-page: 645 year: 2018 end-page: 657 ident: CR11 article-title: Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota publication-title: Front Med doi: 10.1007/s11684-018-0645-9 – volume: 4 start-page: 478 year: 2020 end-page: 492 ident: CR6 article-title: Pathogenesis of nonalcoholic steatohepatitis: an overview publication-title: Hepatol Commun doi: 10.1002/hep4.1479 – volume: 23 start-page: 742 year: 2017 end-page: 752 ident: CR16 article-title: Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4 publication-title: Nat Med doi: 10.1038/nm.4334 – volume: 144 start-page: 197 year: 2015 end-page: 205 ident: CR23 article-title: MicroRNAs affect dendritic cell function and phenotype publication-title: Immunology doi: 10.1111/imm.12390 – volume: 67 start-page: 1716 year: 2018 end-page: 1725 ident: CR20 article-title: Human gut microbiome: hopes, threats and promises publication-title: Gut doi: 10.1136/gutjnl-2018-316723 – ident: CR8 – volume: 59 start-page: 328 year: 2014 end-page: 339 ident: CR9 article-title: Microbiota-liver axis in hepatic disease publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.26494 – ident: CR27 – volume: 385 start-page: 1559 year: 2021 end-page: 1569 ident: CR5 article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease publication-title: N Engl J Med doi: 10.1056/NEJMoa2029349 – ident: CR19 – volume: 27 start-page: 2170 year: 2022 end-page: 2180 ident: CR18 article-title: Key regulatory miRNAs in lipid homeostasis: implications for cardiometabolic diseases and development of novel therapeutics publication-title: Drug Discov Today doi: 10.1016/j.drudis.2022.05.003 – volume: 103 start-page: 22 year: 2019 end-page: 27 ident: CR1 article-title: Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation publication-title: Transplantation doi: 10.1097/tp.0000000000002484 – volume: 18 start-page: 425 year: 2017 end-page: 432 ident: CR21 article-title: The outer membrane vesicles: secretion system type zero publication-title: Traffic (Copenhagen, Denmark) doi: 10.1111/tra.12488 – volume: 121 start-page: 27 year: 2017 end-page: 42 ident: CR26 article-title: Hepatic stellate cells as key target in liver fibrosis publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2017.05.007 – volume: 192 start-page: 131 year: 2023 end-page: 142 ident: CR2 article-title: Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Ir J Med Sci doi: 10.1007/s11845-022-02988-x – volume: 397 start-page: 2212 year: 2021 end-page: 2224 ident: CR3 article-title: Non-alcoholic fatty liver disease publication-title: Lancet (London, England) doi: 10.1016/s0140-6736(20)32511-3 – volume: 13 start-page: 351 year: 2020 end-page: 368 ident: CR14 article-title: Gut dysbiosis and increased intestinal permeability drive microRNAs, NLRP-3 inflammasome and liver fibrosis in a nutritional model of non-alcoholic steatohepatitis in adult male Sprague Dawley rats publication-title: Clin Exp Gastroenterol doi: 10.2147/ceg.S262879 – volume: 60 start-page: 940 year: 2014 end-page: 947 ident: CR10 article-title: Altered profile of human gut microbiome is associated with cirrhosis and its complications publication-title: J Hepatol doi: 10.1016/j.jhep.2013.12.019 – ident: CR13 – volume: 281 start-page: 2503 year: 2014 end-page: 2524 ident: CR12 article-title: Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease publication-title: FEBS J doi: 10.1111/febs.12806 – volume: 20 start-page: 461 year: 2019 end-page: 472 ident: CR17 article-title: Dietary lipids, gut microbiota and lipid metabolism publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-019-09512-0 – volume: 214 start-page: 17 year: 2019 end-page: 29 ident: CR15 article-title: siRNA- and miRNA-based therapeutics for liver fibrosis publication-title: Transl Res doi: 10.1016/j.trsl.2019.07.007 – volume: 46 start-page: 269 year: 2005 end-page: 278 ident: CR25 article-title: Ozanne SE (2022) Effects of maternal diet-induced obesity on metabolic disorders and age-associated miRNA expression in the liver of male mouse offspring publication-title: Int J Obes doi: 10.1038/s41366-021-00985-1 – ident: 3529_CR27 doi: 10.3390/jcm5030038 – ident: 3529_CR4 doi: 10.3389/fendo.2020.597648 – volume: 144 start-page: 197 year: 2015 ident: 3529_CR23 publication-title: Immunology doi: 10.1111/imm.12390 – volume: 27 start-page: 2170 year: 2022 ident: 3529_CR18 publication-title: Drug Discov Today doi: 10.1016/j.drudis.2022.05.003 – ident: 3529_CR8 doi: 10.3390/ijms20020395 – volume: 29 start-page: 77 year: 2023 ident: 3529_CR7 publication-title: Clin Mol Hepatol doi: 10.3350/cmh.2022.0237 – volume: 59 start-page: 328 year: 2014 ident: 3529_CR9 publication-title: Hepatology (Baltimore, MD) doi: 10.1002/hep.26494 – volume: 12 start-page: 645 year: 2018 ident: 3529_CR11 publication-title: Front Med doi: 10.1007/s11684-018-0645-9 – ident: 3529_CR19 doi: 10.3390/cells9061534 – volume: 23 start-page: 742 year: 2017 ident: 3529_CR16 publication-title: Nat Med doi: 10.1038/nm.4334 – volume: 385 start-page: 1559 year: 2021 ident: 3529_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMoa2029349 – volume: 121 start-page: 27 year: 2017 ident: 3529_CR26 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2017.05.007 – volume: 192 start-page: 131 year: 2023 ident: 3529_CR2 publication-title: Ir J Med Sci doi: 10.1007/s11845-022-02988-x – volume: 67 start-page: 1716 year: 2018 ident: 3529_CR20 publication-title: Gut doi: 10.1136/gutjnl-2018-316723 – volume: 18 start-page: 425 year: 2017 ident: 3529_CR21 publication-title: Traffic (Copenhagen, Denmark) doi: 10.1111/tra.12488 – ident: 3529_CR13 doi: 10.1093/advances/nmy078 – volume: 397 start-page: 2212 year: 2021 ident: 3529_CR3 publication-title: Lancet (London, England) doi: 10.1016/s0140-6736(20)32511-3 – volume: 13 start-page: 351 year: 2020 ident: 3529_CR14 publication-title: Clin Exp Gastroenterol doi: 10.2147/ceg.S262879 – volume: 20 start-page: 461 year: 2019 ident: 3529_CR17 publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-019-09512-0 – volume: 60 start-page: 940 year: 2014 ident: 3529_CR10 publication-title: J Hepatol doi: 10.1016/j.jhep.2013.12.019 – volume: 281 start-page: 2503 year: 2014 ident: 3529_CR12 publication-title: FEBS J doi: 10.1111/febs.12806 – volume: 103 start-page: 22 year: 2019 ident: 3529_CR1 publication-title: Transplantation doi: 10.1097/tp.0000000000002484 – volume: 27 start-page: 206 year: 2019 ident: 3529_CR22 publication-title: Trends Microbiol doi: 10.1016/j.tim.2018.10.011 – volume: 46 start-page: 269 year: 2005 ident: 3529_CR25 publication-title: Int J Obes doi: 10.1038/s41366-021-00985-1 – volume: 214 start-page: 17 year: 2019 ident: 3529_CR15 publication-title: Transl Res doi: 10.1016/j.trsl.2019.07.007 – volume: 43 start-page: 125 year: 2017 ident: 3529_CR24 publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2017.02.003 – volume: 4 start-page: 478 year: 2020 ident: 3529_CR6 publication-title: Hepatol Commun doi: 10.1002/hep4.1479 |
SSID | ssj0039364 |
Score | 2.3344734 |
Snippet | Background
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.
Aims
This study was aimed to investigate... The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. This study was aimed to investigate the correlation... The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.BACKGROUNDThe gut dysbiosis correlates with... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 909 |
SubjectTerms | Family Medicine General Practice Internal Medicine Medicine Medicine & Public Health Original Article |
Title | MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1 |
URI | https://link.springer.com/article/10.1007/s11845-023-03529-w https://www.ncbi.nlm.nih.gov/pubmed/37823951 https://www.proquest.com/docview/2876634853 |
Volume | 193 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB0VVkJcqrZ8dGmLXIkbWNrEH0mO2wq6bRUOaJHgFDm2AyvagNhsUc_9451JHBDaaqXeHdvKs8dvNDNvAA5U6pSspODClQ4dFG95mvmYizStHNJrNxJUnJyf6sm5_HahLkJR2LzPdu9Dkq2lfip2Q2eEqokFJw3PjD-swUCh706JXOfxuLe_IhM6aC9HPIq1CqUy_57j-XO0xDGX4qPts3PyCl4GvsjGHcCv4YWv38BGHiLiW_Anp4y6s9MxV0hixR27qdHCOfStGXVJ-TUjLsnQx-ema4Y7s4yAbW6vPSVTN7M5K3-zNmiOG2DIB9nVomE_Z51CU2MYZZ2H1C5maseoeQ6dGxw9zT99zaNtmJ4cTz9PeGiswK2QSYMWEJ2OODGmorrZJLWlxrvrTEJKhaoUlbAmtZl3WmpXKYOcqtJejirrhTKx2IF13Ld_C8yMUo8oa-eqTEqfZs7o2JKKvUPuopMhRP3vLWwQHafeFz-KJ7lkgqRASIoWkuJhCIeP39x1khsrR3_sUSvwZlC4w9T-djEv0BdEOiWRjwxht4PzcT6BxEgguRzCUY9vES7vfMVie_83_B1s4vkMiT7vYb25X_gPyGGach8G4y-X34_326P7Fwjq6e0 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB0VKgEX1JYWFvrhSr21lnZjx3GO26poackeqkXiZjm2AytgF7FZEGf-ODOJA6qokHp3bCvPHr_RzLwB-JJqn8pKCi586dFBCY7rPCRcaF15pNe-L6g4uRir0ZH8dZwex6KwRZft3oUkG0v9WOyGzghVEwtOGp45v1mBl0gGNJ3lo2TY2V-RCxW1lwd8kKg0lsr8e46_n6MnHPNJfLR5dvZfwWbki2zYAvwaXoTZG1grYkR8C-4Kyqj7Mx7yFEmsuGRnM7RwHn1rRl1SrqfEJRn6-Ny2zXCnjhGw9fw0UDJ1PV2w8pY1QXPcAEM-yE6WNbuYtgpNtWWUdR5Tu5ideUbNc-jc4OhJ8f2gGLyFyf7PyY8Rj40VuBMyq9ECotORZNZWVDebaVcqvLveZqRUmJaiEs5qlwevpPJVapFTVSrIfuWCSG0i3sEq7jvsALN9HRBl5X2VSxl07q1KHKnYe-QuKuvBoPu9xkXRcep9cW4e5ZIJEoOQmAYSc9ODrw_fXLaSG8-O_tyhZvBmULjDzsJ8uTDoCyKdkshHerDdwvkwn0BiJJBc9uBbh6-Jl3fxzGK7_zf8E6yPJsWhOTwY_96DjQT5UJv08x5W66tl-IB8pi4_Nsf3Ht3a60w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bT9RAFD5RTIgvBkRlQXBIfNMJu53ptH1cLhtQujFmSXibTOeiG7Rs3C6EZ_645_TCJRgS36ftpN9cvpNzvu8AfIxTF8sgBReucBigeMvTzEdcpGlwSK9dX5A4OR-ro1P55Sw-u6fir6vdu5Rko2kgl6ay2p25sHsnfMPAhJTFgpOfZ8avnsMLSWpgXNGn0bA7i0UmVOvDPOCDSMWtbObf73h4NT3im49ypfUVNFqBVy13ZMMG7FV45svXsJy32fE1uMmpuu77eMhjJLRixs5LPO0cxtmMOqZcTolXMoz3uWka404tI5Cri5-eCqur6ZwV16xOoOMEGHJD9mNRsd_Txq2pMowq0NsyL2ZKx6iRDq0hHD3J947zwRuYjA4n-0e8bbLArZBJhachBiBRYkwgDW2S2kLhPnYmIdfCuBBBWJPazDsllQuxQX4VlJf9YL2ITSTewhLO268DM_3UI-LKuZBJ6dPMGRVZcrR3yGNU0oNB93u1bQ3IqQ_GL31nnUyQaIRE15Doqx58un1m1thvPDl6p0NN4y6h1Icp_cVirjEuRGolkZv04F0D5-37BJIkgUSzB587fHW7kedPfGzj_4Z_gOVvByN9cjz-ugkvI6RGTf3Pe1iq_iz8FlKbqtiuV-9fVLDvfw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-582-3p+knockdown+alleviates+non-alcoholic+steatohepatitis+by+altering+the+gut+microbiota+composition+and+moderating+TMBIM1&rft.jtitle=Irish+journal+of+medical+science&rft.au=Huang%2C+Shuo&rft.au=Xiao%2C+Xia&rft.au=Wu%2C+Hongman&rft.au=Zhou%2C+Feng&rft.date=2024-04-01&rft.eissn=1863-4362&rft.volume=193&rft.issue=2&rft.spage=909&rft_id=info:doi/10.1007%2Fs11845-023-03529-w&rft_id=info%3Apmid%2F37823951&rft.externalDocID=37823951 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-1265&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-1265&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-1265&client=summon |